Antimetabolites Flashcards

1
Q

What is an Antimetabolite

A

its a structural analogue to an endogenous compound–> interferes with its role in cellular metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Action of ANtimetabloites

A

inhibit DNA, RNA and Protein SYnthesis by blocking the folate pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are Sulfonamides

A

are structural analogues of PABA (p-aminobenzoic acid) which is a precursor in bacterial folic acid synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Organisms susceptible to Suphonamides require

A

extracellular PABA to form Dihydrofolic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Sulfonamides are effective against

A

Sensitive strains of Gram +ive and -ive bacteria
Bacteriostatic drugs
ARE NEVER 1st LINE DRUGS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Spectrum of Sulfonamides

A

Borad Spectrum
Some Enteric bacteria like E.coli and Salmonella
Rickettsiae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What do Sulfonamides not have an effect on

A

Mammalian cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the name of the topical Sulfonamide

A

Silver Sulfadiazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When is Topical Sulfonamide used

A

infected leg ulcers
pressure sores
burn wounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the name of the Oral Absorbable Sulfonamide

A

Sulfamethoxazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

When is the oral Sulfonamide used

A

NEVER USED ON ITS OWN
in combination with Trimethoprim (co-trimoxazole)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MOA of Sulfonamide

A

Its a PABA analogue therefore it binds in its place to Dihydropteroate Synthetase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Resistance Mechanisms against Sulfonamides

A
  1. Overproduction of PABA
  2. Production of Dihydroggen Synthetase with low affininty for Sulfonamides–> bypasses it
  3. Loss of permeability to Sulfonamides
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Absorption and Distribution of Sulfonamides

A

They are well absorbed from the GIT
Wide distribution to tissues and body fluids (including CNS, CSF), placenta and foetus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which Admin method is not used for Sulfonamides

A

Topical admin as it causes allergic rxns
*ONLY used in one case

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Metabolism of Sulfonamides

A

Extensively metabolized in the liver
They are Acetylated and Glucoronidated before being excreted in the urine

17
Q

SEs of Sulfonamides

A

1.N,V,H
2.Precipitation of acetylated metabolites in urine–> Crystalluria: lots of water intake required to make urine more alkaline
3. Allergy: rash, SJS, drug fever
4. Cross-sensitivity with other Sulfanilamide derivatives
5. Danger of Kernicterus
6. Agranulocytosis and thrombocytopenia
7. Photosensitivity
8. Hepatotoxicity
9. Reduced efficacy of COC

18
Q

Why are Kernicterus indicated as a SE for Sulfonamides

A

Bilirubin is pushed from their serum binding sits–> cross BBB and enter Brain nuclei–> cause Toxic Encaphalopathy
*must not be administered during Last 2 wks of pregnancy

19
Q

DIs of Sulfonamides

A

Oral Anticoagulants (warfarin: decr. m)
Sulfonylureas (glibenclamide: decr M=hypo)
Phenytoin: inhibits its metabolism
Methotexate: decr excretion in urine

20
Q

CIs of Sulfonamides

A

Babies in first 3wks of life: incr. risk of haemolysis and Kernicerus
Last trimester of pregnancy (last 2 wks)
Porphyria
G6PD deficiency
Allergy

21
Q

What is Trimethoprim

A

Its a Broad spectrum Bacteriostatci that eventually inhibits DNA Synthesis

22
Q

Uses of Trimethoprim

A

Acute uncomplicated UTIs
Prophylaxis of UTIs
Respiratory tract infections
Chronic Prostatitis

23
Q

How is Trimethoprim used in SA

A

Used in combination with Sulfamethoxazole as Co-trimoxazole

24
Q

MOA of Trimethoprim

A

-Inhibits the bacterial Dihydrofolate Reductase enzyme–> catalyses formation of Tetrahydrofolate form Dihydrofolate
-Inhibits synthesis of Nucleotides
-Inhibits DNA synthesis

25
Q

Resistance Mechanisms against Trimethoprim

A
  1. Reduced cell permeability
  2. Overproduction of Dihydrofolate reductase
  3. Production of an ALtered Reductase with reduced drug binding
26
Q

Absorption and Distribution of Trimethoprim

A

Rapidly absorbed
Widely distributed–> therapeutic levels in bile, CSF, Prostatic tissue, vaginal fluid

27
Q

SEs of Trimethoprim

A

Teratogenic
Glossitis: frequently
Folate Deficiency anemia in people with low folate stores
Skin rashes, pruritus
Nausea, Epigastric Pain
Bone marrow depression: rare
Reduced efficacy of COC

28
Q

Uses of Co-trimoxazole

A

Recommended for use in HIV patients
Prophylaxis and treatment of Pneumocystis Jirovecii Pneumonia
Prophylaxis of Toxoplasmosis and Isospora belli diarrhea
Treatment of choice for Nocardiosis

29
Q

MOA of Co-trimoxazole

A

They interrupt the Synthetic pathway of Tetrahydrofolate in 2 ways:
1. inhibit Dihydropteroate Synthetase (sulfamethaoxazole)
2. inhibit Dihydrofolate Reductase (Trimethoprim)

30
Q

Admin of Co-Trimoxazole

A

1:5 (T:S)–> synergistic
Orally
Large colume of distribution

31
Q

What is the combined effect of Co-trimoxazole

A

Bactericidal
They are Bacteristatic individually

32
Q

Advantages of Co-trimoxazole

A

Delays development of resistance against T
Synergistic action
Wider spectrum than T

33
Q

Excretion of Co-trimoxazole

A

T: mostly unaltered via kidneys
S: Metabolized in Liver and rapidly excreted in the urine

34
Q

SEs of Co-Trimoxazole

A

NV
Skin rashes+anemia
Long term use=folate shortage–> Megoblastic Anemia
Incr. AEs in elderly on DIRUETICS: Thrombocyropenia
Incr. AEs in AIDS patients=fever+ bone marrow depression

35
Q

DIs of Co-Trimoxazole

A
  1. Digoxin levels may incr.
  2. Incr. risk of Thrombocytopenia
  3. Oral Contraceptive
  4. Incr. risk of hypoglycemia with oral antidiabetic agents
  5. May inhibit Phenytoin metabolism
  6. Concurrent use with Pyrimethamine: megoblastic anemia
  7. Rifampicin use leads to decr levels of Co-trimoxazole
  8. Warfarin: incr. bleeding risk
  9. Zidovudine: incr. toxicity risk
  10. Methotrexate: incr. toxicity risk